Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells

被引：49
作者：
Mittelbronn, Michel
Simon, Perikles
Loeffler, Christian
Capper, David
Bunz, Benedikt
Harter, Patrick
Schlaszus, Holger
Schleich, Ariane
Tabatabai, Ghazaleh
Goeppert, Benjamin
Meyermann, Richard
Weller, Michael
Wischhusen, Joerg
机构：
[1] Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Sports Med, D-72074 Tubingen, Germany
[3] Univ Tubingen, Hertie Clin Inst Brain Res, Dept Gen Neurol, D-72074 Tubingen, Germany
[4] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2007年 / 189卷 / 1-2期
关键词：
HLA-E; CD8; cytotoxic T cells; NK cells; human astrocytomas; immune escape;
D O I：
10.1016/j.jneuroim.2007.07.002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
HLA-E is a ligand for the immune-inhibitory NKG2A receptor expressed on NK and T cells. To investigate HLA-E expression and immune cell infiltration in human astrocytic tumors in vivo, we analyzed normal CNS controls and astrocytomas of all WHO grades by immunohistochemistry. Both, CD8+ immune cell infiltration and HLA-E expression were significantly higher in astrocytic tumors than in normal brain. Further, HLA-E expression levels and immune cell infiltration were significantly correlated in WHO grade IV glioblastomas. Thus, HLA-E overexpression in glioblastomas may be triggered by T and NK cell infiltration. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码：50 / 58
页数：9
相关论文
共 51 条
[21]   MECHANISMS BY WHICH HUMAN GLIOMAS MAY ESCAPE CELLULAR IMMUNE ATTACK [J].
GATELY, MK ;
GLASER, M ;
MCCARRON, RM ;
DICK, SJ ;
DICK, MD ;
METTETAL, RW ;
KORNBLITH, PL .
ACTA NEUROCHIRURGICA, 1982, 64 (3-4) :175-197
[22]   Adoptive immunotherapy for cancer: building on success [J].
Gattinoni, L ;
Powell, DJ ;
Rosenberg, SA ;
Restifo, NP .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) :383-393
[23]   Adoptive cellular immunotherapy for the treatment of malignant gliomas [J].
Hayes, RL ;
Arbit, E ;
Odaimi, M ;
Pannullo, S ;
Scheff, R ;
Kravchinskiy, D ;
Zaroulis, C .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 39 (1-2) :31-42
[24]   The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses [J].
Hussain, S. Farzana ;
Yang, David ;
Suki, Dima ;
Aldape, Kenneth ;
Grimm, Elizabeth ;
Heimberger, Amy B. .
NEURO-ONCOLOGY, 2006, 8 (03) :261-279
[25]   Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma [J].
Kondratiev, S ;
Sabo, E ;
Yakirevich, E ;
Lavie, O ;
Resnick, MB .
CLINICAL CANCER RESEARCH, 2004, 10 (13) :4450-4456
[26]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[27]   HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A [J].
Lee, N ;
Llano, M ;
Carretero, M ;
Ishitani, A ;
Navarro, F ;
Lopez-Botet, M ;
Geraghty, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5199-5204
[28]   HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells [J].
Liu, G ;
Ying, H ;
Zeng, G ;
Wheeler, CJ ;
Black, KL ;
Yu, JS .
CANCER RESEARCH, 2004, 64 (14) :4980-4986
[29]   CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse [J].
Masilamani, Madhan ;
Nguyen, Connie ;
Kabat, Juraj ;
Borrego, Francisco ;
Coligan, John E. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (06) :3590-3596
[30]   WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? [J].
Mehling, Matthias ;
Simon, Perikles ;
Mittelbronn, Michel ;
Meyermann, Richard ;
Ferrone, Soldano ;
Weller, Michael ;
Wiendl, Heinz .
ACTA NEUROPATHOLOGICA, 2007, 114 (02) :111-119
123456